Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Art Pappas will participate on a panel at the C21 BioVentures Conference in Napa, Ca titled "Structured Acquisitions: Win-Win or Lose-Lose?"
News | 04. 08. 2009
